Show simple item record

dc.contributor.authorJones, Graeme
dc.contributor.authorNash, Peter
dc.contributor.authorHall, Stephen
dc.date.accessioned2020-08-10T03:31:08Z
dc.date.available2020-08-10T03:31:08Z
dc.date.issued2017
dc.identifier.issn0025-729X
dc.identifier.doi10.5694/mja16.01287
dc.identifier.urihttp://hdl.handle.net/10072/396357
dc.description.abstractThere are now eight approved biological disease-modifying antirheumatic drugs (bDMARDs), two biosimilars and one targeted synthetic DMARD in Australia with a number of new products and biosimilars in the pipeline. bDMARDs have excellent efficacy, especially when combined with traditional DMARDs, and a well characterised but manageable safety profile. These expanded therapeutic options have revolutionised patient care and made remission (including drug free remission) a realistic goal. Evidence of a "window of opportunity" that changes the long term phenotype of the disease has been well established, so therapy should be commenced as early as possible in the disease process and a shared care model between general practitioner and rheumatologist provides the best outcomes. While there is no cure for rheumatoid arthritis, treatment has improved to the point where many patients can achieve a normal quality of life.
dc.description.peerreviewedYes
dc.languageEnglish
dc.language.isoeng
dc.publisherWiley
dc.relation.ispartofpagefrom221
dc.relation.ispartofpageto224
dc.relation.ispartofissue5
dc.relation.ispartofjournalMedical Journal of Australia
dc.relation.ispartofvolume206
dc.subject.fieldofresearchBiomedical and clinical sciences
dc.subject.fieldofresearchClinical sciences
dc.subject.fieldofresearchImmunology
dc.subject.fieldofresearchPsychology
dc.subject.fieldofresearchcode32
dc.subject.fieldofresearchcode3202
dc.subject.fieldofresearchcode3204
dc.subject.fieldofresearchcode52
dc.subject.keywordsScience & Technology
dc.subject.keywordsLife Sciences & Biomedicine
dc.subject.keywordsMedicine, General & Internal
dc.subject.keywordsGeneral & Internal Medicine
dc.subject.keywordsSERIOUS INFECTION
dc.titleAdvances in rheumatoid arthritis
dc.typeJournal article
dc.type.descriptionC1 - Articles
dcterms.bibliographicCitationJones, G; Nash, P; Hall, S, Advances in rheumatoid arthritis, Medical Journal of Australia, 2017, 206 (5), pp. 221-224
dcterms.dateAccepted2017-01-18
dc.date.updated2020-08-09T23:08:03Z
gro.hasfulltextNo Full Text
gro.griffith.authorNash, Peter


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

  • Journal articles
    Contains articles published by Griffith authors in scholarly journals.

Show simple item record